Arcturus Therapeutics (ARCT) Dividend: History, Dates & Yield - 2024
Tags:Dividend History
Arcturus Therapeutics announced a semi annually dividend of $0.01 per ordinary share, payable on 2013-01-15, with an ex-dividend date of 2013-01-08. Arcturus Therapeutics typically pays dividends two times a year.
Find details on Arcturus Therapeutics's dividend performance with a comprehensive history of past and upcoming payments.
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2013-01-08 | $0.01 | semi annually | 2013-01-15 |
| 2013-01-04 | $0.01 | semi annually | 2013-01-15 |
| 2012-12-05 | $0.01 | semi annually | 2012-12-15 |
| 2012-11-06 | $0.01 | semi annually | 2012-11-15 |
| 2012-10-03 | $0.01 | semi annually | 2012-10-15 |
| 2012-09-05 | $0.01 | semi annually | 2012-09-15 |
| 2012-08-06 | $0.01 | semi annually | 2012-08-15 |
| 2012-07-03 | $0.01 | semi annually | 2012-07-15 |
| 2012-06-06 | $0.01 | semi annually | 2012-06-15 |
| 2012-05-04 | $0.01 | semi annually | 2012-05-15 |
Dividend Increase
By comparing Arcturus Therapeutics's dividend growth to other companies, investors can gain insight into how consistent its dividend strategy is and what that means for future payouts. However, dividend growth is just one factor to consider. Investors should also evaluate other metrics, such as earnings growth, payout ratio, and overall financial health, to get a full picture of Walmart's dividend sustainability and potential.
Dividend Yield
Arcturus Therapeutics's current trailing twelve-month (TTM) dividend yield is nan%.
| Company | Dividend Yield | Annual Dividend | Stock Price |
|---|---|---|---|
| Arcturus Therapeutics (ARCT) | NaN% | $0.017 | $17.01 |
| null (null) | null% | 0 | 0 |
| null (null) | null% | 0 | 0 |
Dividend Yield Calculator
Interested in purchasing Arcturus Therapeutics stock? Use our calculator to estimate your expected dividend yield and see how Walmart's consistent payouts could contribute to your long-term investment goals. Understanding your potential returns can help you make an informed decision.
Payout Ratio
Arcturus Therapeutics has a payout ratio of 0.00%. In comparison, 89bio has a payout ratio of -0.00%, while Madrigal Pharmaceuticals's payout ratio is 0.00%.
It's important to note that the payout ratio is just one of many metrics investors use to assess a company's dividend sustainability and growth potential. It should be considered alongside other financial indicators such as earnings, cash flow, and debt levels to gain a complete picture of the company's financial health.
About Arcturus Therapeutics
- Global presence The company operates globally, with a presence in multiple countries across different regions.
- Key segments The company operates in several key segments, including consumer goods, technology, healthcare, and financial services.
- Products/services The company offers a range of products and services, including consumer products, software solutions, medical devices, and banking services.
- Financial stability The company has a strong financial track record, with consistent earnings growth and a history of paying dividends to shareholders.
Frequently Asked Question
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Arcturus Therapeutics stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.